delete Bounty (Penicillin) Regulations (Amendment)
Australian federal regulations amending the Bounty (Penicillin) Act, providing government subsidies for penicillin production. The instrument establishes calculation methods, eligibility criteria, and payment mechanisms for bounty claims on penicillin manufactured in Australia.
Bounty schemes are government market intervention that distorts resource allocation by picking winners and losers. Penicillin is a mature, off-patent pharmaceutical with well-established global supply chains by 2009. Subsidizing domestic penicillin production: 1. Forces consumers and taxpayers to fund potentially inefficient domestic producers 2. Artificially inflates prices compared to competitive global markets 3. Creates bureaucratic compliance overhead that disproportionately burdens smaller manufacturers 4. Protects less-competitive domestic operations at the expense of affordable medicines 5. Represents decades-old industrial policy that has no legitimate role in a modern, open economy 6. The unseen costs include foregone savings from purchasing cheaper imported penicillin and the opportunity cost of capital locked into protected but inefficient production